PTX exerts similar effects on other types of cancer, for example, on lymphocytes from patients with chronic lymphocytic leukemia, PTX induces DNA fragmentation and caspase-3 activation, and decreases NF-kB/p65 phosphorylation (35). Here, NFKB1 is linked to cancer.